Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
BRF S.A. ("BRF") today announces the early tender date results of its previously announced offer to purchase for cash for up to the Maximum Amount...
BRF S.A. ("BRF") today announces the expiration and final results of its previously announced offers to purchase for cash any and all of the...
BRF S.A. ("BRF") communicates to its shareholders and to the market in general that it priced, on the date hereof, an international offering of...
BRF S.A. ("BRF") today announces the commencement of an offer to purchase for cash for its own account and, in the case of the 2026 Notes, on behalf...
BRF S.A. ("BRF"), for its own account and, in the case of the 2026 Notes (as defined below), on behalf of BRF GmbH (the "Subsidiary Issuer"), a...
BRF S.A. ("BRF" or "Company") (B3: BRFS3) (NYSE: BRFS) announces to its shareholders and the general market that it filed, on April 24, 2020, its...
BRF S.A. ("BRF") today announces the expiration and final results of its previously announced offer to purchase for cash up to the Maximum Amount (as ...
BRF S.A. ("BRF") today announces the early tender date results of its previously announced offer to purchase for cash up to the Maximum Amount (as...
BRF S.A. ("BRF") announces that, in respect of its offer to purchase for cash a portion of the outstanding 4.75% Senior Notes due 2024 (the "2024...
BRF S.A. ("BRF") today announces the commencement an offer to purchase for cash (i) any and all of the outstanding 5.875% Senior Notes due 2022 (the...
BRF S.A. ("BRF" or "Company") (B3: BRFS3; NYSE: BRFS) announces to its shareholders and the general market that it filed, on April 29, 2019, its...
BRF is leading innovation in molecular imaging and research in Louisiana through a new $14.2 million, 20,000 sq. ft. Center for Molecular Imaging and ...
Net operating revenue of BRF reached 8.2 billion BRL in Q1 2018 - an increase of 5% over the same quarter of the previous year. The growth reflects...
BRF S.A. ("BRF" ou "Companhia") (B3: BRFS3; NYSE: BRFS), pursuant to CVM Instruction 358, of January 3, 2002, in continuity with the Material Fact...
BRF accelerated revenue growth in the third quarter of 2017, driven by favourable market conditions and the new corporate structure announced in July ...
BRF has recorded net operational revenue of R$ 7.8 billions. The EBITDA margin of the period remains stable at 6.5% as compared to the fourth quarter ...
BRF achieved net operating revenues of R$ 8.59 billion (+1% QOQ) in the fourth quarter of 2016. Gross profit was R$ 1.69 billion (-10.1% QOQ), and...
Despite the challenging scenario in Brazil, BRF's net operating revenue advanced 7.6% in the second quarter of 2016 (2Q16) compared to the same...
BRF's net operating revenue advanced 15.2% in the first quarter of 2016 (1Q16) compared to the same period last year to reach R$8.1 billion. Gross...
Despite the challenging economic scenario, BRF's net income advanced 46% in 2015, to R$3.1 billion. EBITDA came to R$5.7 billion, which represents...
Net Operating Revenue (NOR) of BRF grew 14.4% to reach R$8.3 billion in the third quarter of 2015. EBITDA followed the growth trend to reach R$1.52...
Net operating revenue (NOR) of BRF reached R$7.9 billion in the second quarter of the year, growing by 12.8% from the same period in 2014, as...
BRF, one of leading exporters of animal protein in the world, posted net income of R$461.6 million in the first quarter of 2015, an increase of 42.8% ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
